Consumo de fármacos opiáceos en la ciudad de MadridFactores sanitarios y sociodemográficos asociados

  1. Eduardo J. Pedrero-Pérez
  2. Sara Morales-Alonso
  3. Blanca Álvarez-Crespo
  4. María Teresa Benítez-Robredo
Journal:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Year of publication: 2021

Volume: 33

Issue: 3

Pages: 235-244

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Adicciones: Revista de socidrogalcohol

Abstract

The use of opiate analgesics has led to a health and social emergency in the United States. In Spain, according to official data, the prescription of these drugs has risen dramatically in the last decade. This study explores the prevalence of the use of these drugs and the health and socio-demographic characteristics of their consumers in the city of Madrid. A telephone survey was carried on a stratified, randomised sample, asking about the use of these drugs and whether or not they were medically prescribed. The sample consisted of n=8,845 subjects aged between 15 and 98 years. Sixteen percent stated that they had used these drugs in the last year and 9.1% had taken them in the last two weeks. Consumption was more frequent among women, lower social class and lower level of education. Among the youngest group (15- 29 years old) 12.5% had already used it. Those who use opioids report worse perceived health, lower quality of life, more mental health problems, more loneliness, more use of other psychoactive drugs, more frequent daily use of tobacco and less problematic consumption of alcohol. Ten percent of those who use them do so without a doctor’s prescription. Combining these data with the prescription data offered by the Ministry of Health, it is necessary to pay attention to a problem that may become apparent in the coming years, and the adoption of urgent measures to tackle it before it brings the Spanish situation closer to that already well known in countries of our socio-political environment is advised.

Bibliographic References

  • AEMPS (2017). Utilización de medicamentos opioides en España durante el periodo 2008-2015. Ministerio de Sanidad, Servicios Sociales e Igualdad. Recuperado de https:// www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/opioides-2008-2015.pdf
  • AEMPS (2019). Utilización de medicamentos opioides en España durante el periodo 2010-2017. Recuperado de https:// www.aemps.gob.es/medicamentosUsoHumano/observatorio/informes-publicados/informes-opioides-espana-2010-2017.htm
  • Ainsworth, B. E., Haskell, W. L., Whitt, M. C., Irwin, M. L., Swartz, A. M., Strath, S. J.,... Jacobs, D. R. (2000). Compendium of physical activities: An update of activity codes and MET intensities. Medicine and Science in Sports and Exercise, 32, S498-S504. doi:10.1097/00005768- 200009001-00009
  • Ashburn, M. A. y Fleisher, L. A. (2018). Increasing evidence for the limited role of opioids to treat chronic noncancer pain. JAMA, 320, 2427-2428. doi:10.1001/ jama.2018.19327
  • Alonso Babarro, A., Varela Cerdeira, M. y Aparicio Jabalquinto, G. (2003). Evolución del consumo de opioides en un área de Madrid desde 1997 a 2001. Atención Primaria, 32, 390-392.
  • Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A. y Fiellin, D. A. (2008). Non-medical use, abuse and dependence on prescription opioids among US adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94, 38-47. doi:10.1016/j.drugalcdep.2007.09.018
  • Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J.,... Cull, C. (2017). Guideline for opioid therapy and chronic noncancer pain. CMAJ, 189, 659-666. doi:10.1503/cmaj.170363
  • Calabozo Freile, B. (2017). Opioides: Del poco uso … al abuso. El Ojo de Markov, 59. Recuperado de https:// www.saludcastillayleon.es/portalmedicamento/es/ cim-sacyl/ojo-markov/opioides-uso-abuso
  • Casucci, G. y Cevoli, S. (2013). Controversies in migraine treatment: Opioids should be avoided. Neurological Sciences, 34, 125-128. doi:10.1007/s10072-013-1395-8
  • Dale, O., Borchgrevink, P. C., Fredheim, O. M. S., Mahic, M., Romundstad, P. y Skurtveit, S. (2015). Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. BMC Public Health, 15, 461. doi:10.1186/s12889-015-1774-6
  • Davis, M. A., Lin, L. A., Liu, H. y Sites, B. D. (2017). Prescription opioid use among adults with mental health disorders in the United States. Journal of the American Board of Family Medicine, 30, 407-417. doi:10.3122/jabfm.2017.04.170112
  • DeVries, A., Koch, T., Wall, E., Getchius, T., Chi, W. y Rosenberg, A. (2014). Opioid use among adolescent patients treated for headache. Journal of Adolescent Health, 55, 128-133. doi:10.1016/j.jadohealth.2013.12.014
  • DGPNSD. (2018). Edades 2017. Encuesta sobre alcohol y otras drogas en España (EDADES), 1995-2017. Madrid: Ministe- rio de Sanidad, Consumo y bienestar Social; Delegación del Gobierno para el Plan Nacional sobre Drogas. Recuperado de http://www.pnsd.mscbs.gob.es/profesionales/sistemasInformacion/sistemaInformacion/pdf/ EDADES_2017_Informe.pdf
  • Díaz Olalla, J. M. y Benítez Robredo, M. T. (2015). Estudio de salud de la ciudad de Madrid, 2014. Madrid: Madrid Salud. Recuperado de http://www.madridsalud.es/pu- blicaciones/OtrasPublicaciones/EstudioSaludCiudadMadrid.pdf
  • Domingo-Salvany, A., Bacigalupe, A., Carrasco, J. M., Espelt, A., Ferrando, J. y Borrell, C. (2013). Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gaceta Sanitaria, 27, 263-272. doi:10.1016/j.gaceta.2012.12.009
  • Dowell D., Haegerich T.M. y Chou, R. (2016). Guideline for Prescribing Opioids for Chronic Pain United States, 2016. Recommendations and Reports, 65, 1-49. doi:10.15585/mmwr.rr6501e1
  • Edlund, M. J., Martin, B. C., Devries, A., Fan, M. Y., Braden, J. B. y Sullivan, M. D. (2010). Trends in use of opioids for chronic non-cancer pain among individuals with mental health and substance use disorders: The TROUP study. Clinical Journal of Pain, 26, 1-8. doi:10.1097/AJP.0b013e3181b99f35
  • Els, C., Jackson, T. D., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R.,… Straube S. (2017). Adverse events associated with mediumand long-term use of opioids for chronic non-cancer pain: An overview of Cochrane Reviews. Cochrane Database of Systematic Reviews, 10, CD012509. doi:10.1002/14651858.CD012509.pub2
  • Fleming, S., Rabago, D. P., Mundt, M. P. y Fleming, M. F. (2007). CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complementary and Alternative Medicine, 7, 15. doi:10.1186/1472- 6882-7-15
  • Gaspari, S., Papachatzaki, M.M., Koo, J.W., Carr, F.B., Tsimpanouli, M.E., Stergiou, E.,… Zachariou, V. (2014). Nucleus accumbens-specific interventions in rgs9-2 activity modulate responses to morphine. Neuropsychopharmacology, 39, 1968-1977. doi:10.1038/npp.2014.45
  • Goldberg, D. P. y Williams, P. (1998). A user’s guide to the General Health Questionnaire. London: Nfer-Nelson.
  • Guardia Serecigni, J. (2018). Overdose epidemic linked to the prescription of opioid analgesics in the United States. Adicciones, 30, 87-92. doi:10.20882/adicciones.936
  • Hadland, S. E., Cerdá, M., Li, Y., Krieger, M. S. y Marshall, B. D. (2018). Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Internal Medicine, 178, 861-863. doi:10.1001/jamanetworkopen.2018.1999
  • Hadland, S. E., Rivera-Aguirre, A., Marshall, B. D. y Cerdá, M. (2019). Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open, 2, e186007. doi:10.1001/jamanetworkopen.2018.6007
  • Howe, C. Q. y Sullivan, M. D. (2014). The missing ‘P’ in pain management: How the current opioid epidemic highlights the need for psychiatric services in chronic pain care. General Hospital Psychiatry, 36, 99-104. doi:10.1016/j.genhosppsych.2013.10.003
  • Keyes, K. M., Cerdá, M., Brady, J. E., Havens, J. R. y Galea, S. (2014). Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104, 52- 59. doi:10.2105/AJPH.2013.301709
  • Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W. y Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559-574. doi:10.1146/annurev-publhealth-031914-122957
  • Koons, A. L., Greenberg, M. R., Cannon, R. D. y Beauchamp, G. A. (2018). Women and the experience of pain and opioid use disorder: A literature-based commentary. Clinical Therapeutics, 40, 190-196. doi:10.1016/j. clinthera.2017.12.016
  • Lavand’homme, P. y Steyaert, A. (2017). Opioid-free anesthesia opioid side effects: Tolerance and hyperalgesia. Best Practice & Research Clinical Anaesthesiology, 31, 487- 498. doi:10.1016/j.bpa.2017.05.003
  • Lizán, L. y Reig, A. (1999). Adaptación transcultural de una medida de la calidad de vida relacionada con la salud: La versión española de las viñetas COOP/WONCA. Atención Primaria, 24, 75-82.
  • Marshall, B., Bland, M. K., Hulla, R. y Gatchel, R. J. (2019). Considerations in addressing the opioid epidemic and chronic pain within the USA. Pain Management, 9, 131- 138. doi:10.2217/pmt-2018-0070
  • Merskey, H. (1986). International Association for the Study of Pain (IASP): Subcommittee on taxonomy, classification of chronic pain, description of pain terms. Pain, 3, S1-S226.
  • Nechuta, S. J., Tyndall, B. D., Mukhopadhyay, S. y McPheeters, M. L. (2018). Sociodemographic factors, prescription history and opioid overdose deaths: A statewide analysis using linked PDMP and mortality data. Drug and Alcohol Dependence, 190, 62-71. doi:10.1016/j.drugalcdep.2018.05.004
  • Pedrero-Pérez, E. J. y Díaz-Olalla, J. M. (2016). COOP/ WONCA: Fiabilidad y validez de la prueba administrada telefónicamente. Atención Primaria, 48, 25-32. doi:10.1016/j.aprim.2014.12.010
  • PNSD. (2018). Estrategia Nacional sobre Adicciones 2017- 2024. Madrid: Plan Nacional sobre Drogas, Ministerio de Sanidad, Servicios Sociales e Igualdad. Recuperado de https://cendocps.carm.es/documentacion/2018_ Estrategia_Nacional_Adicciones_2017-2024.pdf
  • Randall, C. y Crane, J. (2014). Tramadol deaths in Northern Ireland: A review of cases from 1996 to 2012. Journal of Forensic and Legal Medicine, 23, 32-36. doi:10.1016/j. jflm.2014.01.006
  • Richardson, L. P., Russo, J. E., Katon, W., McCarty, C. A., DeVries, A., Edlund, M. J.,... Sullivan, M. (2012). Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. Journal of Adolescent Health, 50, 553-558. doi:10.1016/j.jadohealth.2011.11.011
  • Rocha, K. B., Pérez, K., Rodríguez-Sanz, M., Borrell, C. y Obiols. J. E. (2011). Propiedades psicométricas y valores normativos del General Health Questionnaire (GHQ12) en población general española. International Journal of Clinical and Health Psychology, 11, 125-139.
  • Rosenquist R. (2019). Use of opioids in the management of chronic non-cancer pain. UpToDate. Recuperado de https://www.uptodate.com/contents/use-of-opioids-inthe-management-of-chronic-non-cancer-pain
  • Ruiz-López, D. y Alonso-Babarro, A. (2019). Consumo de opioides en la Comunidad de Madrid (España) entre 2004 y 2014. Revista Clínica Española, 219, 367-374. doi:10.1016/j.rce.2019.02.002
  • Scherrer, J. F., Svrakic, D. M., Freedland, K. E., Chrusciel, T., Balasubramanian, S., Bucholz, K. K.,... Lustman, P. J. (2014). Prescription opioid analgesics increase the risk of depression. Journal of General Internal Medicine, 29, 491-499. doi:10.1007/s11606-013-2648-1
  • Seal, K. H., Shi, Y., Cohen, G., Cohen, B. E., Maguen, S., Krebs, E. E. y Neylan, T. C. (2012). Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA, 307, 940-947. doi:10.1001/jama.2012.234
  • Skolnick, P. (2018). The opioid epidemic: Crisis and solutions. Annual Review of Pharmacology and Toxicology, 58, 143- 159. doi:10.1146/annurev-pharmtox-010617-052534
  • Socidrogalcohol (2017). Guía de consenso para el buen uso de analgésicos opioides. Gestión de riesgos y beneficios. Valencia: Socidrogalcohol.
  • Sturgeon, J. A. (2014). Psychological therapies for the management of chronic pain. Psychology Research and Behavior Management, 7, 115-124. doi:10.2147/PRBM.S44762
  • Tepper, S. J. (2012). Opioids should not be used in migraine. Headache, 52, 30-34. doi:10.1111/j.1526- 4610.2012.02140.x.
Data source: Dialnet